Specifically, the CK2–HTATSF1–TOPBP1 axis is generally hyperactivated in several tumors, possibly due to gene amplification, and gain-of-function of this pathway sustains tumor cell survival in part by counteracting DNA damage. The gene discussed is HTATSF1; the disease is neoplasm.